A paper by Ken Ishii’s group (Division of Adjuvant Innovation) was published in International Immunology.

Anti-tumor immunity by transcriptional synergy between TLR9 and STING activation

Temizoz B, Hioki K, Kobari S, Jounai N, Kusakabe T, Lee MSJ, Coban C, Kuroda E, Ishii KJ.

Int. Immunol. 2022 Jul 4;34(7):353-364. doi: 10.1093/intimm/dxac012.